The study analysed antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech COVID-19 vaccine, up to three months after their first dose.
from Zee News :India National https://ift.tt/3uUzef1
Karnataka | Regaining momentum from India Today | Nation https://ift.tt/zRGQ1fy
0 Comments